Correlation
The correlation between COLL and HQY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
COLL vs. HQY
Compare and contrast key facts about Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: COLL or HQY.
Performance
COLL vs. HQY - Performance Comparison
Loading data...
Key characteristics
COLL:
-0.31
HQY:
0.70
COLL:
-0.31
HQY:
1.08
COLL:
0.96
HQY:
1.16
COLL:
-0.36
HQY:
0.83
COLL:
-0.66
HQY:
2.17
COLL:
22.40%
HQY:
12.63%
COLL:
39.91%
HQY:
41.28%
COLL:
-73.59%
HQY:
-60.65%
COLL:
-30.29%
HQY:
-11.82%
Fundamentals
COLL:
$947.55M
HQY:
$8.79B
COLL:
$1.22
HQY:
$1.10
COLL:
23.70
HQY:
92.25
COLL:
0.00
HQY:
1.12
COLL:
1.43
HQY:
7.33
COLL:
4.04
HQY:
4.14
COLL:
$664.28M
HQY:
$912.18M
COLL:
$383.21M
HQY:
$559.14M
COLL:
$332.78M
HQY:
$255.15M
Returns By Period
In the year-to-date period, COLL achieves a 1.85% return, which is significantly lower than HQY's 5.24% return. Over the past 10 years, COLL has underperformed HQY with an annualized return of 5.68%, while HQY has yielded a comparatively higher 14.41% annualized return.
COLL
1.85%
5.72%
-4.98%
-12.11%
22.33%
5.76%
5.68%
HQY
5.24%
16.85%
-1.45%
28.82%
17.15%
10.26%
14.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
COLL vs. HQY — Risk-Adjusted Performance Rank
COLL
HQY
COLL vs. HQY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
COLL vs. HQY - Dividend Comparison
Neither COLL nor HQY has paid dividends to shareholders.
Drawdowns
COLL vs. HQY - Drawdown Comparison
The maximum COLL drawdown since its inception was -73.59%, which is greater than HQY's maximum drawdown of -60.65%. Use the drawdown chart below to compare losses from any high point for COLL and HQY.
Loading data...
Volatility
COLL vs. HQY - Volatility Comparison
Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY) have volatilities of 9.75% and 9.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
COLL vs. HQY - Financials Comparison
This section allows you to compare key financial metrics between Collegium Pharmaceutical, Inc. and HealthEquity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
COLL vs. HQY - Profitability Comparison
COLL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Collegium Pharmaceutical, Inc. reported a gross profit of 97.32M and revenue of 177.76M. Therefore, the gross margin over that period was 54.8%.
HQY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, HealthEquity, Inc. reported a gross profit of 189.04M and revenue of 311.82M. Therefore, the gross margin over that period was 60.6%.
COLL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Collegium Pharmaceutical, Inc. reported an operating income of 21.69M and revenue of 177.76M, resulting in an operating margin of 12.2%.
HQY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, HealthEquity, Inc. reported an operating income of 42.15M and revenue of 311.82M, resulting in an operating margin of 13.5%.
COLL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Collegium Pharmaceutical, Inc. reported a net income of 2.42M and revenue of 177.76M, resulting in a net margin of 1.4%.
HQY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, HealthEquity, Inc. reported a net income of 26.37M and revenue of 311.82M, resulting in a net margin of 8.5%.